Background There are limited data from randomized trials regarding whether volume-based,
low-dose computed tomographic (CT) screening can reduce lung-cancer mortality among …

Dendritic cell (DC) based cancer immunotherapy aims at the activation of the immune system,
and in particular tumor-specific cytotoxic T lymphocytes (CTLs) to eradicate the tumor. …

Importance Many patients with advanced non–small cell lung cancer (NSCLC) receiving
immunotherapy show primary resistance. High-dose radiotherapy can lead to increased tumor …

Malignant pleural mesothelioma (MPM) is an uncommon but aggressive and treatment resistant
neoplasm with low survival rates. In the last years we assisted to an exponential growth …

Background Radiotherapy might augment systemic antitumoral responses to immunotherapy.
In the PEMBRO-RT (phase 2) and MDACC (phase 1/2) trials, patients with metastatic non-…

Dendritic cells (DCs) are antigen-presenting cells (APCs) that are essential for the activation
of immune responses. In various malignancies, these immunostimulatory properties are …

Purpose Maintenance therapy is associated with improved survival in patients with non–small-cell
lung cancer (NSCLC), but few studies have compared active agents in this setting. …

Background Macrolide resistance is an increasing problem; there is therefore debate about
when to implement maintenance treatment with macrolides in patients with chronic …

Background Myeloid-derived suppressor cells (MDSC) are a heterogeneous population of
immature cells that accumulates in tumour-bearing hosts. These cells are induced by tumour-…

Context: In vitro and in vivo experiments have assigned both oncosuppressive and oncogenic
properties to thyroid hormones. Population-based studies have found inconclusive results. …